(2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(-(hydroxymethyl)piperidine-3,4,5-triol; N-(2-Hydroxyethyl)-1-deoxynojirimycin; BAY-1099
An α-glucosidase inhibitor which induces an enhanced and prolonged release of glucagon-like peptide-1, regulating appetite and stabilizing body weight in humans. Displays anti-atherothrombotic effect by reducing platelet activation and raising circulating adiponectin levels in patients with type 2 diabetes. Clinically useful antidiabetic agent.
Is it cell-permeable?
≥98% by TLC
Is this a salt?
Protect from moisture
Maximum time for storage
DMSO (50 mg/ml) or H2O (60 mg/ml)
For cells, cell lines and tissues in culture till half confluency.